Current stock page

Catalysts

MEDP Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Diagnostics & ResearchScore data as of Oct 21, 2026

MEDPMedpace Holdings, Inc.

Healthcare / Medical - Diagnostics & Research

Relative Leader / Watch

Strong Relative Position

NeutralEdge 9/10
$662.48+$40.05 (+6.43%)

Latest quote

  • Momentum
    88
  • Value
    30
  • Quality
    79
  • Risk resilience
    55
  • Sentiment
    —
algovestiq.comScore data as of Oct 21, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
—

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 63/100

Momentum 88/100 and sentiment — before the next covered event.

Recent coverage
5 articles

Updated Oct 21, 2026 · Sentiment 41.57%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 88/100AIQ Edge 9/10 Strong Relative Position
Beat rate
100%
6 of 6 reported periods
Average surprise
+10.1%
Across covered historical reports
Latest result
+6.8%
Jul 22, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Oct 28, 2026—$4.45——$714.27M—
Oct 21, 2026—$4.44——$714.47M—
Jul 22, 2026—$3.98$4.25+6.8%$689.51M$707.33M
Apr 22, 2026—$3.92$4.28+9.2%$697.6M$706.6M
Feb 9, 2026—$4.19$4.67+11.5%$689.31M$708.45M
Oct 22, 2025—$3.53$3.86+9.3%$641M$659.9M
Jul 21, 2025—$2.98$3.10+4.0%$538.77M$603.31M
Apr 21, 2025—$3.06$3.67+19.9%$526.34M$558.57M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
2
Buy
11
Hold
1
Sell
12-month analyst target
$576.06
-13.04% versus current price
Based on 9 analyst observations. Targets are estimates, not predictions.
Low target
$400.00
-39.62% vs latest price
Average target
$576.06
-13.04% vs latest price
High target
$700.00
+5.66% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date—

Upcoming earnings date not available yet.

Sentiment score—

News pressure around the setup.

Momentum score88

Where event reaction would show up first.

AIQ score63/100

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
9
Average target
$576.06
Target upside
-13.04%
Target range
$400.00 - $700.00
90-day revisions
4

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
5
Neutral
0
Negative
0
gurufocus.com · Oct 15, 2026

WASATCH ADVISORS LP Exits Smith Douglas Homes Corp (SDHC) -- Shares Look 56% Undervalued on GF Value

A Complete Liquidation of the Homebuilder Position On 2026-09-23, WASATCH ADVISORS LP (Trades, Portfolio) executed a sell transaction involving Smith Douglas Ho

gurufocus.com · Oct 15, 2026

WASATCH ADVISORS LP Trims XPEL Inc (XPEL) Stake -- Shares Look 14% Undervalued on GF Value

A Strategic Reduction in a High-Conviction Holding WASATCH ADVISORS LP (Trades, Portfolio) disclosed a reduction in its position in XPEL Inc (XPEL) on 2026-09-3

gurufocus.com · Oct 15, 2026

WASATCH ADVISORS LP Trims UFP Technologies Inc (UFPT) Stake -- Shares Look 5% Overvalued on GF Value

A Strategic Reduction in a High-Flying Medical Device Manufacturer On Sept. 30, 2026, WASATCH ADVISORS LP (Trades, Portfolio) executed a reduction of 130,453 sh

gurufocus.com · Oct 15, 2026

Wasatch Advisors LP Trims Suncrete Inc (RMIX) Stake by 4.60% as Construction Materials Play Faces Headwinds

Wasatch Advisors LP, a Salt Lake City-based investment firm, executed a reduction in its position in Suncrete Inc (RMIX) on September 30, 2026. The transaction

gurufocus.com · Oct 15, 2026

WASATCH ADVISORS LP Trims Suja Life Inc (SUJA) Stake by 44.51% in Q3 2026

A Significant Reduction in a Newly Public Beverage Play On Sept. 30, 2026, Salt Lake City-based investment manager WASATCH ADVISORS LP (Trades, Portfolio) execu

Open full news and sentiment

MEDP Catalysts FAQ

What are the next catalysts for MEDP stock?

MEDP's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move MEDP stock?

Upcoming events that could move MEDP include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could MEDP's next earnings report affect the stock?

MEDP's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive MEDP stock higher?

MEDP could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt MEDP stock?

MEDP could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.